Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) insider Edwin Reisz sold 50,000 shares of the stock in a transaction on Thursday, August 20th. The shares were sold at an average price of $11.50, for a total transaction of $575,000.00. Following the transaction, the insider owned 1,397,897 shares of the company's stock, valued at $16,075,815.50. This trade represents a 3.45% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
Aveanna Healthcare Stock Performance
Aveanna Healthcare stock opened at $13.70 on Tuesday. The company's 50-day moving average price is $9.71 and its 200-day moving average price is $7.95. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 4.47. The company has a market cap of $2.99 billion, a PE ratio of 11.14, a price-to-earnings-growth ratio of 0.92 and a beta of 1.90. Aveanna Healthcare Holdings Inc. has a twelve month low of $5.93 and a twelve month high of $13.98.
Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) last announced its quarterly earnings results on Thursday, August 13th. The company reported $0.22 EPS for the quarter, beating analysts' consensus estimates of $0.17 by $0.05. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. The firm had revenue of $670.48 million during the quarter, compared to the consensus estimate of $638.61 million. On average, equities research analysts forecast that Aveanna Healthcare Holdings Inc. will post 0.68 EPS for the current fiscal year.
Aveanna Healthcare News Summary
Here are the key news stories impacting Aveanna Healthcare this week:
- Positive Sentiment: Royal Bank of Canada raised its price target from $10 to $16 and upgraded its rating to “outperform,” implying additional upside from the stock’s recent trading level. Benzinga analyst coverage
- Positive Sentiment: Truist Financial lifted its price target from $11 to $15 while maintaining a “hold” rating. The higher target reflects improved valuation expectations, even though Truist remains cautious on the shares. Benzinga analyst coverage
- Negative Sentiment: Insiders and major shareholders disclosed approximately 48.6 million shares of sales at an average price of $11.50, worth roughly $558.5 million. Sellers included Paul R. Vigano, Robert M. Williams Jr., and J.H. Whitney Equity Partners V, as well as CEO Jeff Shaner, director Rodney D. Windley, and insider Edwin C. Reisz. Although the sellers retained sizable positions, the volume of stock coming to market may pressure AVAH and raise questions about shareholder confidence. SEC insider transaction filing
Institutional Investors Weigh In On Aveanna Healthcare
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. AQR Capital Management LLC boosted its position in Aveanna Healthcare by 21.2% in the 1st quarter. AQR Capital Management LLC now owns 26,280 shares of the company's stock valued at $142,000 after buying an additional 4,602 shares during the period. Goldman Sachs Group Inc. grew its stake in Aveanna Healthcare by 8.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 339,853 shares of the company's stock worth $1,842,000 after acquiring an additional 25,974 shares in the last quarter. Jane Street Group LLC increased its position in shares of Aveanna Healthcare by 522.0% during the first quarter. Jane Street Group LLC now owns 75,081 shares of the company's stock worth $407,000 after acquiring an additional 63,010 shares during the period. Creative Planning increased its position in shares of Aveanna Healthcare by 15.1% during the second quarter. Creative Planning now owns 47,025 shares of the company's stock worth $246,000 after acquiring an additional 6,171 shares during the period. Finally, JPMorgan Chase & Co. increased its position in shares of Aveanna Healthcare by 65.0% during the second quarter. JPMorgan Chase & Co. now owns 158,265 shares of the company's stock worth $828,000 after acquiring an additional 62,348 shares during the period. Institutional investors own 87.96% of the company's stock.
Analyst Upgrades and Downgrades
AVAH has been the subject of several analyst reports. Truist Financial raised their target price on shares of Aveanna Healthcare from $11.00 to $15.00 and gave the stock a "hold" rating in a report on Monday. BMO Capital Markets raised their price objective on shares of Aveanna Healthcare from $10.00 to $14.00 and gave the stock an "outperform" rating in a research note on Friday, August 14th. Raymond James Financial boosted their target price on Aveanna Healthcare from $13.00 to $15.00 and gave the company a "strong-buy" rating in a research report on Friday, August 14th. Royal Bank Of Canada upped their target price on Aveanna Healthcare from $10.00 to $16.00 and gave the company an "outperform" rating in a research note on Monday. Finally, UBS Group raised their price target on Aveanna Healthcare from $8.00 to $13.00 and gave the stock a "neutral" rating in a research note on Friday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $12.89.
Get Our Latest Stock Report on Aveanna Healthcare
Aveanna Healthcare Company Profile
(
Get Free Report)
Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna's offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.
In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
